ZIL

⚡ Flash Summary

ZIL Limited has issued a clarification regarding unusual movement in its share price. The company stated that its management and directors are unaware of any undisclosed material events or information that would require disclosure under PSX regulations, except for previously announced information. Furthermore, ZIL Limited clarified that the company, its directors, spouses, and executives are not involved in any trading activity related to the company’s shares. The company has requested the CDC to procure trading activity data to determine the individuals behind the share price volatility.

📌 Key Takeaways

• 🚨 Unusual share price movement in ZIL Limited.
• 📅 Clarification issued on November 24, 2025, in response to PSX letter dated November 21, 2025.
• ℹ️ Management and directors unaware of undisclosed material events (as of November 13, 2025).
• ✅ Compliant with PSX Regulation 5.6.3 regarding information disclosure.
• 🚫 Company, directors, spouses, and executives not involved in trading activity.
• 🔍 No director or executive shared information impacting share price.
• 📜 Statement compliant with Section 97 of Securities Act 2015 and PSX Regulations clause 5.6.3.
• 🏛️ CDC requested to investigate trading activity to identify responsible parties.
• 🤔 Purpose is to determine the cause of substantial volatility.
• ✉️ ZIL Limited will keep authorities informed about the investigation results.
• 🇵🇰 Regulatory compliance emphasized throughout the announcement.

🎯 Investment Thesis

HOLD. Given the uncertainty surrounding the share price volatility and the ongoing investigation, it is prudent to maintain a HOLD position. The company’s clarification indicates no known involvement of insiders, but the investigation’s outcome could significantly impact the stock. Without further information, especially regarding financial performance, a BUY or SELL recommendation cannot be justified. A neutral stance is appropriate until the situation is clarified.